How much do you know about CBD’s effect on diseases?

CBD has many benefits and people want to know about CBD’s effect on some diseases. Today, we are going to talk about this topic and discuss the effect of CBD on these diseases. Click here for cbd oil toronto.

Buy CBD oil, also to decrease diabetes?

Cannabidiol has anti-inflammatory properties. In the case of type 1 diabetes, the immune system destroys the pancreas: it attacks its cells. This destruction is due to an inflammatory infiltration of the cells of the immune system in the islets of Langerhans of the pancreas; β-cells producing insulin is destroyed. This is initially an inflammation of the pancreas. A clinical study in hemorheology and microcirculation (conducted in 2016 by Clinical Hemorheology and Microcirculation, here) shows that cannabidiol can relieve inflammation of the pancreas. This is a first victory for the beginnings of research into the cannabidiol-drug. Go to this website, if you want to get information about cbd oil toronto.

Cannabidiol to fight Alzheimer’s, Crohn’s disease or ulcerative colitis?

Cannabidiol contained in CBD oil, in long-term treatment, can help prevent the occurrence of memory loss, mainly with regard to face recognition.

Many other studies address the fact that cannabinoids can contribute to the elimination of beta-amyloid plaque in brain cells, which is characteristic of Alzheimer’s disease. Here you will find multiple studies on cannabidiol related to Alzheimer’s disease.

Crohn’s disease and ulcerative colitis, also being chronic inflammatory diseases, of the intestine, are cases in which cannabidiol could show the effectiveness of its anti-inflammatory properties.

Parkinson’s and Huntington’s

This study (thesis work conducted at the Faculty of Pharmacy of the University of Grenoble in 2014) tells us that neurodegenerative diseases such as Parkinson’s disease could benefit from cannabinoid-based drugs. The same goes for Huntington’s disease affecting the basal ganglia (in the brain). The results of a randomized, double-blind study suggest that cannabidiol may possibly improve the quality of life of patients with Parkinson’s disease without psychiatric comorbidities.

Cannabinoid receptors are involved in different mechanisms of neuroprotection (Van Der Stelt & Di Marzo, 2005). The antioxidant, anti-glutamatergic and anti-inflammatory effects of cannabinoids, and hence cannabidiol, are now recognized and their interests in the treatment of many neurodegenerative diseases are making their way into the scientific community towards the perspective of cannabinoid-based therapy . Cannabinoids by its multiple characteristics are promising candidates in the development of new therapeutic strategies.